(Press-News.org) Patients with non-small-cell lung cancer survive longer if they are taking beta-blockers while receiving radiotherapy, according to a study of 722 patients published in the cancer journal Annals of Oncology [1] today (Wednesday).
Researchers at the University of Texas MD Anderson Cancer Center (Houston, USA) reviewed the progress and outcomes of patients who had received radiotherapy as their main or first line of treatment for cancer (known as "definitive radiotherapy" i.e. radiotherapy that is delivered at doses of 60 Gy or more, with the intention of curing the disease).
They found that 155 patients who were on beta-blockers for other conditions, such as high blood pressure and heart disease, survived for an average of 23.7 months compared to the 567 patients who were not on beta-blockers, who survived for an average of 18.6 months – an improvement in survival of 22% after adjusting for other factors such as age, stage of the disease, whether or not chemotherapy was given at the same time, chronic obstructive pulmonary disease and the use of aspirin.
Beta-blocker use was also associated with improvements in survival without the disease spreading to other parts of the body (distant metastasis-free survival) and survival without the disease recurring (disease-free survival). Beta-blockers made no difference in the length of time a patient survived without the disease progressing in the part of the lungs where it had first occurred (locoregional progression-free survival).
Assistant Professor Dr Daniel Gomez, at the Department of Radiation Oncology at the MD Anderson Cancer Center, said: "Despite recent improvements in radiotherapy and chemotherapy for non-small-cell-lung cancer, the prognosis of this disease is poor, with less than 15% of patients surviving for five years after diagnosis. A major cause of death is the process of metastasis, when cancer cells travel from the original tumour to other parts of the body. Therefore, we urgently need to find new ways of blocking the development of metastases in these patients.
"Our results suggest that the use of beta-blockers during radiotherapy may help to prevent the formation of metastases, and could lead directly or indirectly to improved care for patients with non-small-cell lung cancer. As far as we are aware, our study is the first analysis to show a survival benefit associated with the use of beta-blockers during definitive radiotherapy in patients with NSCLC. However, prospective studies are needed to investigate these findings further and to discover whether improved survival is affected by when and for how long patients need to take beta-blockers. We are excited about using our study as a starting point for further investigations."
The mechanism underlying the development of metastases is complex, but may involve chronic stress conditions and prolonged exposure to stress hormones. One of these hormones, norepinephrine, has been shown to stimulate the migration of tumour cells to other parts of the body. Receptors on the surface of cells, which beta-blockers are designed to inhibit, are involved in this process.
Professor Zhongxing Liao, from the Department of Radiation Oncology at the MD Anderson Cancer Center, said: "Our findings agree with results from previous studies suggesting that beta-blockers have a specific effect on the cascade of events that lead to metastases. The fact that their use did not affect locoregional progression-free survival suggests that the drugs affect this metastatic cascade rather than the primary tumour."
Patients in the study had been treated with definitive radiotherapy from 1998 to 2010 at the MD Anderson Center. The 155 patients on beta-blockers were taking a range of different types of the drug and at a range of doses depending on the medication and their need. The researchers said there were not enough patients in the study to discover whether the choice of beta-blocker might be important, but that most of the study patients who did well were on a selective beta-blocker. "This finding requires further investigation," said Prof Liao.
She added: "Due to practical limitations, we were unable to assess whether any other medications that patients were taking while receiving radiotherapy may have influenced the results. This should be the subject of future analyses, ideally in clinical trials."
Dr Gomez said the researchers were discussing the possibility of a clinical trial to investigate the efficacy of new treatments, such as beta-blockers, for lung cancer, but that this would require external funding. "Another future direction would be to examine further the molecular characteristics that lead to this apparent clinical improvement in survival. For instance, what cellular pathways are involved in patients that experience a benefit with beta-blockers, and can these mechanisms be altered in another way to achieve the same benefit?"
###
Notes:
[1] "Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy", by H.M. Wang, Z.X. Liao, R. Komaki, J.W. Welsh, M.S. O'Reilly, J.Y. Chang, Y. Zhuang, L.B. Levy, C. Lu and D.R. Gomez. Annals of Oncology. doi:10.1093/annonc/mds616
Lung cancer patients live longer if they use beta-blockers while receiving radiotherapy
2013-01-09
ELSE PRESS RELEASES FROM THIS DATE:
Cheating slime mold gets the upper hand
2013-01-09
A 'cheater' mutation (chtB) in Dictyostelium discoideum, a free living slime mould able to co-operate as social organism when food is scarce, allows the cheater strain to exploit its social partner, finds a new study published in BioMed Central's open access journal BMC Evolutionary Biology. The mutation ensures that when mixed with 'normal' Dictyostelium more than the fair share of cheaters become spores, dispersing to a new environment, and avoiding dying as stalk cells.
Dictyostelium have an unusual life style. They generally live as individual amoeboid cells, eating ...
Triple mix of blood pressure drugs and painkillers linked to kidney problems
2013-01-09
Patients who take a triple combination of blood pressure drugs and common painkillers are at an increased risk of serious kidney problems, especially at the start of treatment, finds a study published on bmj.com today.
Although the absolute risk for individuals is low, it is still something doctors and patients should be aware of, say the researchers.
Acute kidney injury (also known as kidney failure) is a major public health concern. It occurs in more than 20% of hospital inpatients and is associated with around half of all potentially preventable deaths in hospital. ...
Cancer screening unlikely to benefit patients with a short life expectancy
2013-01-09
Breast and colorectal cancer screening should be targeted towards patients with a life expectancy greater than 10 years: for any shorter life expectancy the harms are likely to outweigh the benefits, concludes a study published on bmj.com today.
The authors stress that their results "should not be used to deny screening for patients with limited life expectancy" but "should inform decision making which aims to account for patient preferences and values while maximising benefits and minimising risks."
Guidelines recommend screening healthy older patients because complications ...
BMJ raises concerns over the effectiveness of a costly and invasive procedure for melanoma
2013-01-09
A special report published by the BMJ today finds that thousands of melanoma patients around the world are undergoing an expensive and invasive procedure called sentinel node biopsy, despite a lack of clear evidence and concerns that it may do more harm than good.
Although not recommended for routine use in England, it has become the standard care for melanoma patients in several countries including the United States, where it was estimated to cost over $686m in 2012.
Melanoma is the fifth most common cancer in the UK, affecting one in 60 people. In the US it affects ...
Reduction in air pollution from wood stoves associated with significantly reduced risk of death
2013-01-09
Male deaths from all-causes, but particularly cardiovascular and respiratory disease, could be significantly reduced with a decrease in biomass smoke (smoke produced by domestic cooking and heating and woodland fires), a paper published today on bmj.com suggests.
The researchers say this could have significant impact on further interventions to reduce pollution from this source.
Although a large amount of research has been carried out on the adverse health effects of air pollution, no studies have reported reductions in deaths associated with interventions to reduce ...
First oral drug for spinal cord injury improves movement in mice, study shows
2013-01-09
COLUMBUS, Ohio – An experimental oral drug given to mice after a spinal cord injury was effective at improving limb movement after the injury, a new study shows.
The compound efficiently crossed the blood-brain barrier, did not increase pain and showed no toxic effects to the animals.
"This is a first to have a drug that can be taken orally to produce functional improvement with no toxicity in a rodent model," said Sung Ok Yoon, associate professor of molecular & cellular biochemistry at Ohio State University and lead author of the study. "So far, in the spinal cord ...
Synthetic 'poop' can cure C. difficile infection, study finds
2013-01-09
A synthetic "poop" developed at the University of Guelph can cure nasty gastrointestinal infections caused by Clostridium difficile, a toxin-producing bacterium.
A study on the artificial stool was published today in the inaugural issue of Microbiome, a new peer-reviewed science journal.
The stool – a "super-probiotic" called RePOOPulate – was created by Guelph microbiologist Emma Allen-Vercoe to replace human fecal matter used in stool transplants, a known treatment for C. difficile.
She made the super-probiotic from purified intestinal bacterial cultures grown ...
Earth-size planets common in galaxy
2013-01-09
An analysis of the first three years of data from NASA's Kepler mission, which already has discovered thousands of potential exoplanets, contains good news for those searching for habitable worlds outside our solar system.
It shows that 17 percent of all sun-like stars have planets one to two times the diameter of Earth orbiting close to their host stars, according to a team of astronomers from the University of California, Berkeley, and the University of Hawaii at Manoa.
This estimate includes only planets that circle their stars within a distance of about one-quarter ...
'Tricorder' invention could put medical diagnosis and terrorism prevention in the palm of the hand
2013-01-09
COLUMBIA, Mo. -- The hand-held scanners, or tricorders, of the Star Trek movies and television series are one step closer to reality now that a University of Missouri engineering team has invented a compact source of X-rays and other forms of radiation. The radiation source, which is the size of a stick of gum, could be used to create inexpensive and portable X-ray scanners for use by doctors, as well as to fight terrorism and aid exploration on this planet and others.
"Currently, X-ray machines are huge and require tremendous amounts of electricity," said Scott Kovaleski, ...
'Universal' personality traits may not be universal after all
2013-01-09
(Santa Barbara, Calif.) –– For decades, consensus among psychologists has held that a group of five personality traits –– or slight variations of these five –– are a universal feature of human psychology. However, a study by anthropologists at UC Santa Barbara raises doubt about the veracity of that five-factor model (FFM) of personality structure as it relates to indigenous populations. Their findings appear in the current issue of the American Psychological Association's Journal of Personality and Social Psychology.
Studying the Tsimane, an isolated indigenous group ...